1.
Severe injection site reactions after subcutaneous administration of Sayana®: a retrospective, post-marketing analysis of WHO and Swiss spontaneous pharmacovigilance reports. Swiss Med Wkly [Internet]. 2017 May 10 [cited 2025 Oct. 18];147(1920):w14432. Available from: https://www.smw.ch/index.php/smw/article/view/2300